In Vivo Therapeutics Holdings logo

NVIV In Vivo Therapeutics Holdings

Invivo Therapeutics Holdings Corp. operates as a research and clinical-stage biotechnology company, which engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries. Its clinical development program is the Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord. The company was founded by Joseph P. Vacanti, Frank M. Reynolds, and Robert Langer in January 2005 and is headquartered in Cambridge, MA.

Healthcare Biotechnology SIC: Unknown CIK: 1292519

Auditor raised Going Concern issues

Transaction DateRecipientSharesTypePriceValue